Shin Na Taba Fada Maka Wannan, Jurassic Park, Jurassic Mulkin Duniya, Sam neill
Sam Neill, dan wasan kwaikwayo na "Jurassic Park", an gano shi da ciwon daji na jini
Maris 2023: Babi na farko na memoir na Sam Neill zai zama babban abin girgiza ga wanda bai da masaniya game da shi. Ya fara da ban dariya sosai: babban yarn game da 'yarsa Elena ana tambaya game da jor mahaifinta ..
CAR T Gwajin Kwayoyin Jiyya, gwaje-gwajen myeloma da yawa
Gwajin asibiti akan CAR-T Cell far ga marasa lafiya da BCMA/TACI-tabbatacce koma baya da/ko refractory mahara myeloma
Brief Summary: A study of APRIL CAR-T cells therapy for patients with BCMA/TACI positive relapsed and/or refractory multiple myeloma Detailed Description: This is a single arm, open-label, si..
AZA-JMML-001, Kamfanin Celgene, myelomonocytic cutar sankarar bargo, NCT02447666, Vidaza
FDA ta amince da Azacitidine don sabon kamuwa da cutar sankarar yara myelomonocytic
Yuni 2022: FDA ta amince da miyagun ƙwayoyi azacitidine (Vidaza, Celgene Corp.) ga yara masu sabuwar cutar sankarar bargo na myelomonocytic (JMML).The pharmacokinetics, pharmacodynamics, aminci, da kuma aiki na azacitidine p..
BCMA, CARVYKTI, ciltacabtagene autoleucel, immunomodulatory wakili, Janssen Biotech girma, mai hana proteasome
Ciltacabtagene autoleucel an yarda da shi don sake dawowa ko ɓarna mahara myeloma
Maris 2022: Bayan hudu ko fiye da layin jiyya na farko, gami da mai hana proteasome (PI), wakili na rigakafi (IMiD), da anti-CD38 monoclonal antibody, Hukumar Abinci da Magunguna ta amince da ciltacabtagene au..
Bincike ya ba da shawarar CAR T-Cell far yana tasiri azaman jiyya na layin farko don babban haɗarin babban ƙwayar lymphoma B-cell
Maris 2022: Jami'ar Texas MD Anderson Cancer Center masu bincike sun gano cewa axi-cel, autologous anti-CD19 chimeric antigen receptor (CAR T-cell therapy), lafiya ne kuma ingantaccen maganin layin farko ga marasa lafiya tare da ...
Burkitt lymphoma, Burkitt-kamar lymphoma, Farashin DLBCL, Gaskiya, Rituxan, Rituximab
Rituximab plus chemotherapy an amince da ita ta FDA don alamun ciwon daji na yara
Maris 2022: Hukumar Abinci da Magunguna ta amince da rituximab (Rituxan, Genentech, Inc.) tare da haɗin gwiwar chemotherapy don CD20-positive diffuse big B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Amgen, carfilzomib, Darzalex Faspro, dexamethasone, Janssen Biotech girma, Kyprolis, Multi myeloma
Darzalex faspro, kyprolis, da dexamethasone sun amince da FDA don mahara myeloma
Maris 2022: Daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) da carfilzomib (Kyprolis, Amgen, Inc.) da dexamethasone an amince da su ta Hukumar Abinci da Magunguna don manya marasa lafiya tare da sake dawowa.
Ingancin CAR T-Cell far a kan babban haɗari babba B-Cell lymphoma
Dec 2020: Jami'ar Texas MD Anderson Masu binciken Cibiyar Ciwon daji sun gano cewa axi-cel, autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy, lafiya ne kuma ingantaccen maganin layin farko ga marasa lafiya tare da ..
Asciminib, na kullum myeloid cutar sankarar bargo, Novartis AG, Ph+ CML, Philadelphia chromosome, Scemblix
An yarda da Asciminib don cutar sankarar bargo na chromosome na zamani na Philadelphia
Nov 2021: An ba Asciminib (Scemblix, Novartis AG) amincewa da gaggawa ta Cibiyar Abinci da Magunguna don marasa lafiya da Philadelphia chromosome-positive myeloid leukemia (Ph + CML) a cikin lokaci na yau da kullun (CP) wanda ke da p..
bALL, Brexucabtagene autoleucel, Farashin Pharma, Tecartus, ZUMA-3
Brexucabtagene autoleucel an amince da shi ta FDA don sake dawowa ko refractory B-cell precursor m lymphoblastic cutar sankarar bargo.
Oktoba 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) Hukumar Abinci da Magunguna ta amince da ita ga manya marasa lafiya da suka koma ko tantanin halitta B-cell precursor m lymphoblastic leukemia (ALL). A cikin..